ArticleCureus2025
Impact of the COVID-19 Pandemic on Postpartum Depression and Length of Stay in a Large Academic Center in New Jersey.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPostpartum depression (PPD) is screened by the Edinburgh Postnatal Depression Scale (EPDS), where a score of 10 - 12 indicates possibly having PPD and a score of ≥ 13 indicates PPD. This publication aims to describe the impact of the COVID-19 pandemic on the hospital length of stay (LOS) of parturients following a PPD diagnosis.
methodThe CDC identified five peak months of COVID-19 cases in NJ between January 2020 and March 2022; 10,967 parturients at Hackensack University Medical Center (HUMC) filled out the EPDS after delivery and were split into two groups based on their EPDS scores: 10-12 and ≥ 13. Groups were then correlated with the five peak months, assessing the LOS via the t-score and one-way ANOVA.
resultsAcross the five peak months, 71 (3.67%) were found to have an EDPS of ≥ 10, with 71.8% in group 1 and 28.2% in group 2. In these months, the average LOS was 2.2 days, significantly less than the LOS in patients with an EDPS of ≥ 10 (p = 0.03). The average LOS in groups 1 and 2 was 2.57 and 2.4 days, respectively, with no significant difference. Conclusion: The difference in the LOS, not accounting for extenuating factors, means that individuals with possible or diagnosed PPD had a longer stay, which may be associated with proper psychiatric care being employed prior to discharge. Further research assessing the LOS for PPD following COVID-19 may elucidate whether proper care is still being given for PPD following delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.